Mirtazapine
Product Images NDC 50090-5296

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 50090-5296). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

S:\exranbaxy\san-reg\regulatory\spl\deepa\2020\mrtazapine\20191016_f23631be-c7ae-46e9-b771-a70be17bc9f0\mirtazapine-01.jpg (Mirtazapine 01)

Chemical structure of Mirtazapine, showing its distinctive fused ring system including pyridine, piperazine, and methyl groups, as depicted in the image.*

FDA Label Image

Label Image (Lbl500905296)

Mirtazapine 15 mg tablet bottle label from A-S Medication Solutions. The label includes the product NDC 50090-5296-0, storage instructions at 68 to 77 degrees Fahrenheit, a lot number field, and indicates the package contains 30 tablets. Dosage instructions direct to see the package insert.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.